Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2020

03.11.2020 | Perspective

Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety

verfasst von: Joseph W. Frank, MD, MPH, Amy S. B. Bohnert, PhD, MHS, Friedhelm Sandbrink, MD, Marsden McGuire, MD, MBA, Karen Drexler, MD

Erschienen in: Journal of General Internal Medicine | Sonderheft 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Evidence-based treatment of opioid use disorder, the prevention of opioid overdose and other opioid-related harms, and safe and effective pain management are priorities for the Veterans Health Administration (VHA). The VHA Office of Health Services Research and Development hosted a State-of-the-Art Conference on “Effective Management of Pain and Addiction: Strategies to Improve Opioid Safety” on September 10–11, 2019. This conference convened a multidisciplinary group to discuss and achieve consensus on a research agenda and on implementation and policy recommendations to improve opioid safety for Veterans. Participants were organized into three workgroups: (1) managing opioid use disorder; (2) Long-term opioid therapy and opioid tapering; (3) managing co-occurring pain and substance use disorder. Here we summarize the implementation and policy recommendations of each workgroup and highlight important cross-cutting issues related to telehealth, care coordination, and stepped care model implementation.
Literatur
2.
Zurück zum Zitat Bohnert AS, Ilgen MA, Trafton JA, et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014;30(7):605-612.PubMed Bohnert AS, Ilgen MA, Trafton JA, et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014;30(7):605-612.PubMed
5.
Zurück zum Zitat Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645.CrossRef Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645.CrossRef
6.
Zurück zum Zitat Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019;380(24):2285-2287.CrossRef Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019;380(24):2285-2287.CrossRef
7.
Zurück zum Zitat Frank JW, Lovejoy TI, Becker WC, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181-191.CrossRef Frank JW, Lovejoy TI, Becker WC, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181-191.CrossRef
8.
Zurück zum Zitat Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Netw Open. 2019;2(6):e196373.CrossRef Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Netw Open. 2019;2(6):e196373.CrossRef
10.
Zurück zum Zitat Ilgen MA, Bohnert AS, Chermack S, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385-1393.CrossRef Ilgen MA, Bohnert AS, Chermack S, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385-1393.CrossRef
11.
Zurück zum Zitat Kemp J, Bossarte RM. Surveillance of suicide and suicide attempts among veterans: addressing a national imperative. Am J Public Health. 2012;102 Suppl 1:e4-5.CrossRef Kemp J, Bossarte RM. Surveillance of suicide and suicide attempts among veterans: addressing a national imperative. Am J Public Health. 2012;102 Suppl 1:e4-5.CrossRef
12.
Zurück zum Zitat Kerns RD, Philip EJ, Lee AW, Rosenberger PH. Implementation of the Veterans Health Administration National Pain Management Strategy. Transl Behav Med. 2011;1(4):635-643.CrossRef Kerns RD, Philip EJ, Lee AW, Rosenberger PH. Implementation of the Veterans Health Administration National Pain Management Strategy. Transl Behav Med. 2011;1(4):635-643.CrossRef
13.
Zurück zum Zitat Kligler B, Bair MJ, Banerjea R, et al. Clinical policy recommendations from the VHA State-of-the-Art Conference on non-pharmacological approaches to chronic musculoskeletal pain. J Gen Intern Med. 2018;33(Suppl 1):16-23.CrossRef Kligler B, Bair MJ, Banerjea R, et al. Clinical policy recommendations from the VHA State-of-the-Art Conference on non-pharmacological approaches to chronic musculoskeletal pain. J Gen Intern Med. 2018;33(Suppl 1):16-23.CrossRef
14.
Zurück zum Zitat Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence brief: Barriers and facilitators to use of medications for opioid use disorder. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs, 2019. VA ESP Project #09-009. https://www.hsrd.research.va.gov/publications/esp/reports.cfm. Accessed 3 March 2020. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence brief: Barriers and facilitators to use of medications for opioid use disorder. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs, 2019. VA ESP Project #09-009. https://​www.​hsrd.​research.​va.​gov/​publications/​esp/​reports.​cfm. Accessed 3 March 2020.
15.
Zurück zum Zitat Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Evidence brief: Benefits and harms of long-term opioid dose reduction or discontinuation in patients with chronic pain. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs; 2019. VA ESP Project #09-199. Available at: https://www.hsrd.research.va.gov/publications/esp/reports.cfm. Accessed 3 Mar 2020. Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Evidence brief: Benefits and harms of long-term opioid dose reduction or discontinuation in patients with chronic pain. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs; 2019. VA ESP Project #09-199. Available at: https://​www.​hsrd.​research.​va.​gov/​publications/​esp/​reports.​cfm. Accessed 3 Mar 2020.
16.
Zurück zum Zitat Nahin RL. Severe Pain in Veterans: The effect of age and sex, and comparisons with the general population. J Pain. 2017;18(3):247-254.CrossRef Nahin RL. Severe Pain in Veterans: The effect of age and sex, and comparisons with the general population. J Pain. 2017;18(3):247-254.CrossRef
17.
19.
Zurück zum Zitat Nevedal AL, Wagner TH, Ellerbe LS, Asch SM, Koenig CJ. A qualitative study of primary care providers’ experiences with the Veterans Choice Program. J Gen Intern Med. 2019;34(4):598-603.CrossRef Nevedal AL, Wagner TH, Ellerbe LS, Asch SM, Koenig CJ. A qualitative study of primary care providers’ experiences with the Veterans Choice Program. J Gen Intern Med. 2019;34(4):598-603.CrossRef
Metadaten
Titel
Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety
verfasst von
Joseph W. Frank, MD, MPH
Amy S. B. Bohnert, PhD, MHS
Friedhelm Sandbrink, MD
Marsden McGuire, MD, MBA
Karen Drexler, MD
Publikationsdatum
03.11.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe Sonderheft 3/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06295-y

Weitere Artikel der Sonderheft 3/2020

Journal of General Internal Medicine 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.